Premium
PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Jaeger U.,
McGuirk J.,
Worel N.,
Riedell P.,
Fleury I.,
Borchmann P.,
Forcina A.,
Chu J.,
Leung M.,
Pacaud L.,
Waller E.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.7_2632
Subject(s) - medicine , pembrolizumab , oncology , diffuse large b cell lymphoma , clinical trial , salvage therapy , phases of clinical research , lymphoma , chemotherapy , immunotherapy , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom